Abbey Group still faces uphill climb in Cambridge
The Abbey Group’s challenges in filling 840 Memorial Drive in Cambridge appear to be as stubborn as ever, despite the firm’s recent lease extension with drug developer Bluebird Bio. The BlueBird Bio deal’s terms were not disclosed. However an Abbey Group spokesman with Reagan Communications Group in Boston said new the agreement means Bluebird Bio […]